Los Angeles Capital Management’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.9K Sell
376
-7,508
-95% -$337K ﹤0.01% 1775
2025
Q4
$246K Buy
+7,884
New +$246K ﹤0.01% 1170
2025
Q3
Sell
-12,214
Closed -$449K 1540
2025
Q2
$449K Hold
12,214
﹤0.01% 896
2025
Q1
$480K Buy
12,214
+22
+0.2% +$991 ﹤0.01% 757
2024
Q4
$567K Hold
12,192
﹤0.01% 783
2024
Q3
$551K Buy
12,192
+1,888
+18% +$89.8K ﹤0.01% 834
2024
Q2
$508K Buy
10,304
+1,475
+17% +$60.1K ﹤0.01% 855
2024
Q1
$303K Buy
8,829
+116
+1% +$4.19K ﹤0.01% 998
2023
Q4
$321K Buy
+8,713
New +$201K ﹤0.01% 999
2023
Q3
Sell
-13,582
Closed -$278K 1242
2023
Q2
$278K Buy
13,582
+2,012
+17% +$30.1K ﹤0.01% 1025
2023
Q1
$174K Buy
11,570
+433
+4% +$9.56K ﹤0.01% 1130
2022
Q4
$265K Sell
11,137
-3,149
-22% -$91.3K ﹤0.01% 1070
2022
Q3
$503K Buy
14,286
+7,727
+118% +$328K ﹤0.01% 929
2022
Q2
$229K Buy
6,559
+854
+15% +$30.3K ﹤0.01% 1226
2022
Q1
$282K Buy
5,705
+2,000
+54% +$111K ﹤0.01% 1262
2021
Q4
$287K Sell
3,705
-47
-1% -$4.82K ﹤0.01% 1253
2021
Q3
$401K Hold
3,752
﹤0.01% 1163
2021
Q2
$500K Sell
3,752
-200
-5% -$23.3K ﹤0.01% 1164
2021
Q1
$489K Sell
3,952
-5,493
-58% -$834K ﹤0.01% 1228
2020
Q4
$1.33M Sell
9,445
-145
-2% -$16.1K 0.01% 810
2020
Q3
$729K Sell
9,590
-30
-0.3% -$1.87K ﹤0.01% 943
2020
Q2
$436K Buy
9,620
+330
+4% +$11.8K ﹤0.01% 1163
2020
Q1
$284K Buy
+9,290
New +$250K ﹤0.01% 1074

Other funds holding TWST

Los Angeles Capital Management's TWST Position: Q1 2026 in Review

Los Angeles Capital Management reduced its Twist Bioscience (TWST) stake by 95% in Q1 2026, selling an estimated $337K and leaving 376 shares worth $17.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1775.

Los Angeles Capital Management first reported a position in TWST in Q1 2020 and has held it in 23 quarters since. The position peaked at $1.33M in Q4 2020. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Los Angeles Capital Management held 376 shares of Twist Bioscience worth $17.9K as of Q1 2026.
  • Los Angeles Capital Management sold 7,508 Twist Bioscience shares in Q1 2026, an estimated $337K.
  • Twist Bioscience made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #1775 holding.
  • Los Angeles Capital Management first reported a position in Twist Bioscience in Q1 2020 and has held it in 23 quarters since.
  • Los Angeles Capital Management's Twist Bioscience position peaked at $1.33M in Q4 2020.
  • 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.